Evidence map›Paper›PMID 39323341›Full record

ReviewPharmaceutical nanotechnology2025

Recent Advancements in Nanopharmaceuticals for Novel Drug Delivery Systems.

Kai Bin Liew, Ee Va Koh, Xue Er Kong, Nurdina Aleyah Ismail, Rabiatul Adawiyah Abu Bakar, Phei Er Kee, Syed Haroon Khalid, Hiu Ching Phang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pharmaceutical nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kai Bin LiewFaculty of Pharmacy, University of Cyberjaya, Persiaran Bestari, Cyberjaya,63000, Selangor, Malaysia.
Ee Va KohFaculty of Pharmacy, University of Cyberjaya, Persiaran Bestari, Cyberjaya,63000, Selangor, Malaysia.
Xue Er KongFaculty of Pharmacy, University of Cyberjaya, Persiaran Bestari, Cyberjaya,63000, Selangor, Malaysia.
Nurdina Aleyah IsmailFaculty of Pharmacy, University of Cyberjaya, Persiaran Bestari, Cyberjaya,63000, Selangor, Malaysia.
Rabiatul Adawiyah Abu BakarFaculty of Pharmacy, University of Cyberjaya, Persiaran Bestari, Cyberjaya,63000, Selangor, Malaysia.
Phei Er KeeBiorefinery and Bioprocessing Engineering Laboratory, Department of Chemical Engineering and Materials Science, Yuan Ze University, Chungli, Taoyuan, 320, Taiwan.
Syed Haroon KhalidDepartment of Pharmaceutics, Faculty of Pharmacy, Universiti Teknologi Mara, Puncak Alam, Selangor, 42300, Malaysia.
Hiu Ching PhangFaculty of Pharmacy, University of Cyberjaya, Persiaran Bestari, Cyberjaya,63000, Selangor, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles have found applications across diverse sectors, including agriculture, food, cosmetics, chemicals, mechanical engineering, automotive, and oil and gas industries. In the medical field, nanoparticles have garnered considerable attention due to their great surface area, high solubility, rapid dissolution, and enhanced bioavailability. Nanopharmaceuticals are specifically designed to precisely deliver drug substances to targeted tissues and cells, aiming to optimize therapeutic efficacy while minimizing potential adverse effects. Furthermore, nanopharmaceuticals offer advantages, such as expedited therapeutic onset, reduced dosages, minimized variability between fed and fasted states, and enhanced patient compliance. The increasing interest in nanopharmaceuticals research among scientists and industry stakeholders highlights their potential for various medical applications from disease management to cancer treatment. This review examines the distinctive characteristics of ideal nanoparticles for efficient drug delivery, explores the current types of nanoparticles utilized in medicine, and delves into the applications of nanopharmaceuticals, including drug and gene delivery, as well as transdermal drug administration. This review provides insights into the nanopharmaceuticals field, contributing to the development of novel drug delivery systems and enhancing the potential of nanotechnology in healthcare.

Indexed as

Drug Delivery SystemsNanoparticle Drug Delivery SystemNanoparticlesAdministration, CutaneousAnimalsGene Transfer TechniquesHumansNanotechnologyPharmaceutical PreparationsNanoparticle Drug Delivery SystemPharmaceutical Preparationsapplicationscharacteristicsdrug deliverynanoparticlesNanopharmaceuticalsnanotechnology.

Identifiers

PMID39323341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.